These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6535121)

  • 1. [Patency of ductus arteriosus in the premature newborn infant: diagnosis, complications, treatment].
    Agnetti A; Viola P; Zavota L; De Luca F; Squarcia U
    Pediatr Med Chir; 1984; 6(5):609-15. PubMed ID: 6535121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Indomethacin and persistent ductus arterious in the pre-term newborn infant with respiratory insufficiency].
    Hurtado del Río D; Holden Barker AM; Segura MA; Lozano González C
    Arch Inst Cardiol Mex; 1981; 51(1):83-8. PubMed ID: 7212861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants.
    Kim ES; Kim EK; Choi CW; Kim HS; Kim BI; Choi JH; Park JS; Moon KC
    J Pediatr; 2010 Nov; 157(5):745-50.e1. PubMed ID: 20598319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of indomethacin in the closure of patent ductus arteriosus in premature newborn infants with cardiac insufficiency. Analysis of 14 cases].
    Atik E; Moromizato JH; Zan R; Ajzenberg M; Esher R; Diniz EM; Souza AT; Martins CO; Bastos JC
    Arq Bras Cardiol; 1984 Sep; 43(3):185-9. PubMed ID: 6535546
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence and clinical features of patent ductus arteriosus in low-birthweight infants: a prospective analysis of 150 consecutively born infants.
    Siassi B; Blanco C; Cabal LA; Coran AG
    Pediatrics; 1976 Mar; 57(3):347-51. PubMed ID: 1256945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 10. The patent ductus arteriosus.
    Friedman WF; Fitzpatrick KM; Merritt TA; Feldman BH
    Clin Perinatol; 1978 Sep; 5(2):411-36. PubMed ID: 371899
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of patency of the ductus arteriosus after surgical ligation in premature infants.
    Daniels SR; Reller MD; Kaplan S
    Pediatrics; 1984 Jan; 73(1):56-8. PubMed ID: 6691041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of symptomatic patent ductus arteriosus to respiratory distress in premature newborn infants.
    Cotton RB
    Clin Perinatol; 1987 Sep; 14(3):621-33. PubMed ID: 3311542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ductus arteriosus persistens in the newborn with respiratory distress syndrome. Experience with indomethacin and operative ligation].
    Frisch H; Hammerer I; Heinz-Erian P; Gschnitzer F
    Monatsschr Kinderheilkd; 1982 Jun; 130(6):480-3. PubMed ID: 7132996
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating prostaglandin E2 concentrations and incidence of patent ductus arteriosus in preterm infants with respiratory distress syndrome.
    Clyman RI; Brett C; Mauray F
    Pediatrics; 1980 Nov; 66(5):725-9. PubMed ID: 7432878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for persistent ductus arteriosus patency during indomethacin treatment.
    Chorne N; Jegatheesan P; Lin E; Shi R; Clyman RI
    J Pediatr; 2007 Dec; 151(6):629-34. PubMed ID: 18035143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When to treat the patent ductus arteriosus with indomethacin in very-low-birth-weight infants.
    Mahony L; Heymann MA; Carnero V; Brett C; Clyman RI
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():491-4. PubMed ID: 6221636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.